annual total liabilities:
$15.91M-$10.05M(-38.70%)Summary
- As of today (August 1, 2025), ELVN annual total liabilities is $15.91 million, with the most recent change of -$10.05 million (-38.70%) on December 31, 2024.
- During the last 3 years, ELVN annual total liabilities has fallen by -$140.30 million (-89.81%).
- ELVN annual total liabilities is now -90.06% below its all-time high of $160.12 million, reached on December 31, 2022.
Performance
ELVN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$14.27M-$1.64M(-10.31%)Summary
- As of today (August 1, 2025), ELVN quarterly total liabilities is $14.27 million, with the most recent change of -$1.64 million (-10.31%) on March 31, 2025.
- Over the past year, ELVN quarterly total liabilities has dropped by -$10.79 million (-43.05%).
- ELVN quarterly total liabilities is now -91.09% below its all-time high of $160.12 million, reached on December 31, 2022.
Performance
ELVN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ELVN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | -43.0% |
| 3 y3 years | -89.8% | - |
| 5 y5 years | -89.5% | -90.9% |
ELVN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.1% | at low | -91.1% | +50.1% |
| 5 y | 5-year | -90.1% | at low | -91.1% | +50.1% |
| alltime | all time | -90.1% | at low | -91.1% | +50.1% |
ELVN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $14.27M(-10.3%) |
| Dec 2024 | $15.91M(-38.7%) | $15.91M(-6.5%) |
| Sep 2024 | - | $17.03M(-23.0%) |
| Jun 2024 | - | $22.11M(-11.8%) |
| Mar 2024 | - | $25.07M(-3.5%) |
| Dec 2023 | $25.96M | $25.96M(+111.2%) |
| Sep 2023 | - | $12.29M(+29.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $9.51M(-17.0%) |
| Mar 2023 | - | $11.45M(-92.8%) |
| Dec 2022 | $160.12M(+2.5%) | $160.12M(+0.8%) |
| Sep 2022 | - | $158.89M(+1.7%) |
| Dec 2021 | $156.22M(+3.2%) | - |
| Dec 2021 | - | $156.22M |
| Dec 2020 | $151.31M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Enliven Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of ELVN is $15.91M
What is the all time high annual total liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total liabilities is $160.12M
What is Enliven Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, ELVN annual total liabilities has changed by -$10.05M (-38.70%)
What is Enliven Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of ELVN is $14.27M
What is the all time high quarterly total liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total liabilities is $160.12M
What is Enliven Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, ELVN quarterly total liabilities has changed by -$10.79M (-43.05%)